<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31723</article-id><article-id pub-id-type="doi">10.7554/eLife.31723</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>p53 suppresses mutagenic RAD52 and POLθ pathways by orchestrating DNA replication restart homeostasis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-73943"><name><surname>Roy</surname><given-names>Sunetra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-96989"><name><surname>Tomaszowski</surname><given-names>Karl-Heinz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-96990"><name><surname>Luzwick</surname><given-names>Jessica W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-96991"><name><surname>Park</surname><given-names>Soyoung</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-96992"><name><surname>Li</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33764"><name><surname>Murphy</surname><given-names>Maureen</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7644-7296</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-78872"><name><surname>Schlacher</surname><given-names>Katharina</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7226-6391</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cancer Biology</institution>, <institution>UT MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Genomic Medicine</institution>, <institution>UT MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Molecular and Cellular Oncogenesis Program</institution>, <institution>The Wistar Institute</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-17580"><name><surname>Powell</surname><given-names>Simon</given-names></name><role>Reviewing editor</role><aff><institution>Memorial Sloan Kettering Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>KSchlacher@mdanderson.org</email> (KS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>01</month><year>2018</year></pub-date><volume>7</volume><elocation-id>e31723</elocation-id><history><date date-type="received"><day>03</day><month>09</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Roy et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Roy et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-31723-v1.pdf"/><abstract><p>Classically, p53 tumor suppressor acts in transcription, apoptosis, and cell cycle arrest. Yet, replication-mediated genomic instability is integral to oncogenesis, and p53 mutations promote tumor progression and drug-resistance. By delineating human and murine separation-of-function p53 alleles, we find that p53 null and gain-of-function (GOF) mutations exhibit defects in restart of stalled or damaged DNA replication forks driving genomic instability genetically separable from transcription activation. By assaying protein-DNA fork interactions in single cells, we unveil a p53-MLL3-enabled recruitment of MRE11 DNA replication restart nuclease. Importantly, p53 defects or depletion unexpectedly allow mutagenic RAD52 and POLq pathways to hijack stalled forks, which we find reflected in p53 defective breast-cancer patient COSMIC mutational signatures. These data uncover p53 as a keystone regulator of replication homeostasis within a DNA restart network. Mechanistically, this has important implications for development of resistance in cancer therapy. Combined, these results define an unexpected role for p53-mediated suppression of replication genome instability.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004917</institution-id><institution>Cancer Prevention and Research Institute of Texas</institution></institution-wrap></funding-source><award-id>R1312</award-id><principal-award-recipient><name><surname>Schlacher</surname><given-names>Katharina</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>K22CA175262</award-id><principal-award-recipient><name><surname>Schlacher</surname><given-names>Katharina</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Maureen Murphy, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="http://firebrowse.org/?cohort=BRCA&amp;download_dialog=true" source-id-type="uri"><collab>The Cancer Genome Atlas Research Network</collab>, <year>2016</year><x>,</x> <source>Breast Cancer TCGA dataset (TCGA-BRCA)</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://firebrowse.org/?cohort=BRCA&amp;download_dialog=true">http://firebrowse.org/?cohort=BRCA&amp;download_dialog=true</ext-link><x>,</x> <comment>Publicly available from the NCI GDC Data Portal (https://cancergenome.nih.gov)</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-31723-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>